
    Original Text: Have relapsed or progressed after prior anti- PD-(L)1 therapy as follows:
    Disease/Condition: Relapse, Progressive Disease
    Procedure: none
    Drug: Durvalumab
    Biomarker: none
    Computable Rule: RP_PD_1_Mono == True, RP_PD_1_Combo == False, RP_PD_1_Single == True

Criterion:
    Patients must have received at least one dose of study drug and have had at least one post-baseline tumor assessment

Output:
    Original Text: Patients must have received at least one dose of study drug and have had at least one post-baseline tumor assessment
    Disease/Condition: None
    Procedure: None
    Drug: None
    Biomarker: None
    Computable Rule: Tx_at_least_one == True, TumorAssessment_at_least_one == True

Criterion:
    Patients must have received at least one